Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
0.270
+0.014 (5.47%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $6.91 million as of October 29, 2024. Its market cap has decreased by -80.97% in one year.
Market Cap
6.91M
Enterprise Value
14.20M
1-Year Change
-80.97%
Ranking
Category
Stock Price
$0.27
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $6.91M, a decrease of -88.20%. That is a compound annual growth rate of -51.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 6.60M | -65.98% |
| Dec 29, 2023 | 19.40M | -81.13% |
| Dec 30, 2022 | 102.80M | -15.53% |
| Dec 31, 2021 | 121.70M | 107.86% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Check-Cap | 6.90M |
| Intelligent Bio Solutions | 6.76M |
| Forte Biosciences | 6.75M |
| Adial Pharmaceuticals | 6.66M |
| Organovo Holdings | 6.58M |
| Aptose Biosciences | 6.52M |
| SunLink Health Systems | 6.36M |
| Portage Biotech | 6.08M |